| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/29/2005 | US20050215766 Allergen from mugwort pollen |
| 09/29/2005 | US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole |
| 09/29/2005 | US20050215598 Phenylalanine derivatives |
| 09/29/2005 | US20050215593 Kaposi's sarcoma; Crohn's disease |
| 09/29/2005 | US20050215582 Substituted pyrrolopyridines |
| 09/29/2005 | US20050215581 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators |
| 09/29/2005 | US20050215579 consisting of lung, renal, prostate, uterine, melanoma and breast tumors; cyclodextrin inclusion compounds aid solubility |
| 09/29/2005 | US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc |
| 09/29/2005 | US20050215550 Pyrazole-derived kinase inhibitors and uses thereof |
| 09/29/2005 | US20050215549 TACE inhibitors |
| 09/29/2005 | US20050215547 Optically active pyridine derivative and a medicament containing the same |
| 09/29/2005 | US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia |
| 09/29/2005 | US20050215520 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
| 09/29/2005 | US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/29/2005 | US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens |
| 09/29/2005 | US20050215477 Treating agonist disorderssuch asd diabetes, obesity, heart dysfunctions, AIDS-related wasting, and kidney, neurological, whole body growth disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern |
| 09/29/2005 | US20050214903 O-superfamily conotoxin peptides |
| 09/29/2005 | US20050214866 Apparatus comprising receptor immobilized on porous support for use as tool in diagnosing allergic diseases; immunotherapy |
| 09/29/2005 | US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents |
| 09/29/2005 | US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins |
| 09/29/2005 | US20050214324 Culturing avian cells permissive for productive replication of the virus in a serum free medium containing a growth factor or an attachment factor, infecting of the cells with the virus, and cultivating in serum free media until progeny virus is produced |
| 09/29/2005 | US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus |
| 09/29/2005 | US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock |
| 09/29/2005 | US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/29/2005 | US20050214292 Monitoring and inhibiting midkine gene expression activity; lupus nephritis; kits |
| 09/29/2005 | US20050214291 Treatment method |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 09/29/2005 | US20050214270 Lactobacillus acidophilus and/or fermentum; reducing immunoglobulin E levels; safe, easy to take |
| 09/29/2005 | US20050214247 Glycodendrimers having biological activity |
| 09/29/2005 | DE102004009325A1 Use of tropisetron having 5-hydroxytryptamine-3 receptor antagonistic activity for preventing the blocking of 5-hydroxytryptamine-3 receptor in organ transplant rejection reaction in transplanted organs e.g. heart, lungs, kidney or liver |
| 09/29/2005 | CA2562388A1 Emulsion-stabilized preparation |
| 09/29/2005 | CA2559272A1 Novel peanut skin extract as a vaccine adjuvant |
| 09/29/2005 | CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols |
| 09/29/2005 | CA2558023A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands |
| 09/29/2005 | CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 09/28/2005 | EP1580556A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 09/28/2005 | EP1580192A2 16-Hydroxyestratrienes as selective estrogens |
| 09/28/2005 | EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/28/2005 | EP1578902A2 Neurotransmission-associated proteins |
| 09/28/2005 | EP1578899A2 Secreted proteins |
| 09/28/2005 | EP1578897A2 Process for inducing functional tolerance to gene transfer products |
| 09/28/2005 | EP1578799A2 Antibodies directed to tumor necrosis factor and uses thereof |
| 09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
| 09/28/2005 | EP1578441A2 Polyphosphazene immunocstimulants |
| 09/28/2005 | EP1578440A1 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins |
| 09/28/2005 | EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 09/28/2005 | EP1463731B1 Dibenzodiazepine derivates, their preparation and use |
| 09/28/2005 | EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 09/28/2005 | EP1361880B1 6-substituted pyrido-pyrimidines |
| 09/28/2005 | EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 09/28/2005 | EP1267905B1 Composition for the treatment of heart failure |
| 09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 09/28/2005 | EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/28/2005 | EP1129194B1 Interleukin-1 homolog zil1a4 |
| 09/28/2005 | EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
| 09/28/2005 | EP0832071B1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
| 09/28/2005 | CN1675363A T-cell epitopes in staphylococcal enterotoxin B |
| 09/28/2005 | CN1675357A Pramyxovirus vectors encoding antibody and utilization thereof |
| 09/28/2005 | CN1675229A Sulfur-containing phospholipid derivatives |
| 09/28/2005 | CN1675209A Dihydropyrazolopyridine compounds |
| 09/28/2005 | CN1675208A Novel fused imidazole derivative |
| 09/28/2005 | CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 09/28/2005 | CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 09/28/2005 | CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 09/28/2005 | CN1675189A Novel use of benzothiazole derivatives |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674939A Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD |
| 09/28/2005 | CN1674935A Biofunctional CpG or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 09/28/2005 | CN1674933A 疫苗组合物 Vaccine compositions |
| 09/28/2005 | CN1674931A T cell receptor CDR3 sequences and methods for detection |
| 09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 09/28/2005 | CN1674910A Combination of azelastine and steroids |
| 09/28/2005 | CN1674901A Novel salt and polymorphs of desloratadine hemifumarate |
| 09/28/2005 | CN1674896A Pharmaceutical compositions comprising FK506 derivatives and the ir use for the treatment of allergic diseases |
| 09/28/2005 | CN1674894A Ether substituted imidazopyridines |
| 09/28/2005 | CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 09/28/2005 | CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 09/28/2005 | CN1673372A A novel marnifi blue mold cell wall surface antigen II its coding sequence and application thereof |
| 09/28/2005 | CN1673371A A new marnifi blue mold cell wall surface antigen I, its coding sequence and application thereof |
| 09/28/2005 | CN1673361A Multipotential cell containing heterogenous nuclear and mitochondrion |
| 09/28/2005 | CN1673230A Prepn of recombinant composite interferon-polyglycol conjugate and conjugate product |
| 09/28/2005 | CN1672721A Immunity raising Chinese medicine and its prepn process |
| 09/28/2005 | CN1672713A Immunity intensifier |
| 09/28/2005 | CN1220695C Inhibitors of nucleoside metabolism |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease |
| 09/28/2005 | CN1220491C Non-oral androgenic steroids used in preparation of medicine for improvement of raising sex hormones combined globulin level |
| 09/27/2005 | US6949649 used as immunomodulators, for inducing cytokine biosynthesis in animals, and in the treatment of diseases, including viral and neoplastic diseases |
| 09/27/2005 | US6949648 Condensed pyrazole derivatives, process for producing the same and use thereof |
| 09/27/2005 | US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |